Bayer Names Julio Triana President of Consumer-Health Division
By Mauro Orru
Bayer appointed Julio Triana as president of its consumer-health division, taking the reins from Heiko Schipper after he asked the company to bring forward the end date of his contract to pursue a career opportunity outside of Bayer.
The German pharmaceutical and agricultural conglomerate said Thursday that Triana, currently head of international commercial operations at Bayer's pharmaceuticals division, would assume his new role on May 1. However, he will be part of Bayer's management board effective April 1.
He joined Bayer in 2002, and served in roles spanning finance, strategy and business development.
Write to Mauro Orru at mauro.orru@wsj.com
(END) Dow Jones Newswires
February 29, 2024 11:28 ET (16:28 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
10 Stocks With the Largest Fair Value Estimate Increases After Q1 Earnings
-
Markets Brief: Inflation Back in the Spotlight
-
AI Is Booming, but Consumer Spending Is Slowing. Which Will Prevail in the Stock Market?
-
What’s Happening In the Markets This Week
-
Is the Era of Volatility-Suppressing Policies Possibly Over?
-
5 Undervalued Stocks That Crushed Earnings for Q1 2024
-
What Does Nvidia’s Stock Split Mean for Investors?
-
After Earnings, Is Home Depot Stock a Buy, a Sell, or Fairly Valued?
-
After Earnings, Is Target Stock a Buy, Sell, or Fairly Valued?
-
Obesity Drug Stocks: Where to Invest Now
-
How to Invest Like Warren Buffett
-
DuPont Split Gives Investors Better Choices
-
2 Wide-Moat Stocks to Consider
-
Live Nation: Breakup Sought by Department of Justice Probably Wouldn’t Affect Fair Value Much
-
After Earnings, Is Applied Materials Stock a Buy, Sell, or Fairly Valued?
-
The Best Energy Stocks to Buy